Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/18680
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.advisor | Valliant, John F. | - |
dc.contributor.author | Edem, Patricia | - |
dc.date.accessioned | 2016-01-05T20:06:28Z | - |
dc.date.available | 2016-01-05T20:06:28Z | - |
dc.date.issued | 2016 | - |
dc.identifier.uri | http://hdl.handle.net/11375/18680 | - |
dc.description.abstract | Cathepsin B is a cysteine protease that is overexpressed in cancers that are likely to metastasize. Molecular imaging can be used to non-invassively detect cathepsin B in vivo in order to characterize cancer progression and treatment response. This thesis describes the development of four different strategies to develop cathepsin B targeted probes. First, an SAR strategy was used to synthesize and test a number of AOMK inhibitors that incorporated iodine. A high affinity (Ki = 180 nM) lead 2.23a was converted to its radioactive analogue [125I]2.23a by optimizing radiolabelling procedures to maximize radiochemical yields (>26%) and radiochemical purities (> 95%). In vivo evaluation showed low tumour uptake (0.05% at 23 h p.i.) due to high in vivo deiodination (thyroid = 20% ID/g at 23 h p.i.). Next, AOMK inhibitors with greater stability were developed using the [ReCO3]+ core either via a direct linkage or a dendrimer platform. The binding affinities of these probes were lower than 2.23a (Ki > 350 nM). A pretargeted approach was then developed that could be used to image cathepsin B in vitro and in vivo. Third, an affinity label was developed using the AOMK warhead linked to TCO giving 4.5 (Ki = 190 nM). A cell assay was developed and intracellular targeting of cathepsin B was observed, something that has not been observed previously with a pretargeted agent in nuclear medicine. Of the five tetrazine based bioorthogonal pairs tested with 4.5, three were sufficient for this approach. The final approach was to use a cathepsin B substrate to link a radiopharmaceutical such as an iodobenzamide used for melanoma imaging. Synthetic strategies were explored to develop the radioactive and non-radioactive analogues. Challenges were encountered during the development of these probes due to stability, which require further optimization. | en_US |
dc.language.iso | en | en_US |
dc.title | DESIGN, SYNTHESIS, AND EVALUATION OF MOLECULAR IMAGING PROBES FOR CATHEPSIN B | en_US |
dc.type | Thesis | en_US |
dc.contributor.department | Chemical Biology | en_US |
dc.description.degreetype | Thesis | en_US |
dc.description.degree | Doctor of Philosophy (PhD) | en_US |
Appears in Collections: | Open Access Dissertations and Theses |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Edem_Patricia_E_finalsubmission2015December_PhD.pdf | Main article | 9.59 MB | Adobe PDF | View/Open |
Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.